These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7620951)

  • 1. Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey.
    Lindblad B; Wakefield TW; Stanley TJ; Bergqvist D; Nichol BJ; Greenfield LJ; Stanley JC; Bergentz SE
    Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):267-71. PubMed ID: 7620951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin and protamine use in peripheral vascular surgery: a comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery.
    Wakefield TW; Lindblad B; Stanley TJ; Nichol BJ; Stanley JC; Bergqvist D; Greenfield LJ; Bergentz SE
    Eur J Vasc Surg; 1994 Mar; 8(2):193-8. PubMed ID: 8181615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Loeliger EA
    Lancet; 1993 Sep; 342(8874):806; author reply 807. PubMed ID: 8103893
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Houben JJ; Nicolai G
    Lancet; 1993 Sep; 342(8874):806-7. PubMed ID: 8103894
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study.
    Ariesen MJ; Tangelder MJ; Lawson JA; Eikelboom BC; Grobbee DE; Algra A;
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):154-9. PubMed ID: 15996602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV
    Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
    Sagnol P; Delahaye JP
    Presse Med; 1991 Feb; 20(7):287-90. PubMed ID: 1826353
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial.
    Lancet; 2000 Jan; 355(9201):346-51. PubMed ID: 10665553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Dörffler-Melly J; Schmidli J; Mahler F
    Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene grafts.
    Hansen KJ; Howe HR; Edgerton TA; Faust KB; Kon ND; Geisinger KR; Meredith JH
    J Vasc Surg; 1986 Aug; 4(2):174-8. PubMed ID: 3735571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.